| Net sales | 933.4M |
| Cost of sales | 577.1M |
| Gross profit | 356.3M |
| Distribution | |
| Research and development | 32.3M |
| Selling and administration | 129M |
| Subtotal | 176.6M |
| Write-off of in-process research and development | |
| Restructuring | 2.1M |
| Total | |
| Operating income | 179.7M |
| Interest, net | |
| Other (income) expense, net | 1M |
| Income from continuing operations before income taxes | 157.3M |
| Income tax expense | 45.9M |
| Income from continuing operations | |
| Income (loss) from discontinued operations, net of tax | |
| Net income | 111.4M |
| Basic | |
| Continuing operations | |
| Discontinued operations | |
| Basic earnings per share | 1.18 |
| Diluted | |
| Continuing operations | |
| Discontinued operations | |
| Diluted earnings per share | 1.18 |
| Basic | 94.2M |
| Diluted | 94.7M |
| Dividends declared per share | 0.09 |